Snake venom toxins (SAIMR Polyvalent Antivenom species) (SAVP-10 toxins)

The target "Snake venom toxins from the 10 African snake species used for immunization" refers to the complex proteomic mixture of toxins found in the venoms of ten medically significant African snake species used to produce the SAIMR (South African Institute for Medical Research) Polyvalent Antivenom [1.2.1, 1.2.3]. These species include the Black Mamba (Dendroaspis polylepis), Green Mamba (Dendroaspis angusticeps), Jameson's Mamba (Dendroaspis jamesoni), Cape Cobra (Naja nivea), Forest Cobra (Naja subfulva), Snouted Cobra (Naja annulifera), Mozambique Spitting Cobra (Naja mossambica), Rinkhals (Hemachatus haemachatus), Puff Adder (Bitis arietans), and Gaboon Adder (Bitis gabonica) [1.2.1, 1.2.2]. The toxins primarily belong to families such as phospholipase A2 (PLA2), three-finger toxins (3FTx), snake venom metalloproteinases (SVMP), and serine proteases [1.1.1]. Biologically, these toxins act by inducing neuromuscular paralysis, systemic hemorrhage, and local tissue necrosis, leading to high morbidity and mortality in snakebite victims [1.1.1, 1.3.1]. Therapeutic intervention involves the use of polyvalent antivenoms, which contain antibodies that bind and neutralize these toxins, as well as emerging small-molecule inhibitors like varespladib and prinomastat that target specific enzymatic components [1.1.1, 1.1.3]. These treatments aim to prevent the binding of toxins to their physiological targets, such as nicotinic acetylcholine receptors or coagulation factors [1.1.1, 1.1.5]. Challenges in therapy include the risk of anaphylaxis and serum sickness associated with equine-derived antivenoms, as well as the difficulty in neutralizing local tissue damage once it has initiated [1.1.4, 1.2.1].

Other names

SAIMR Polyvalent Antivenom antigensSAVP Polyvalent Antivenom toxinsAfrican snake venom toxins (10 species)Snake venom toxins from the 10 African snake species used for immunization

Antibody-mediated neutralization and competitive enzyme inhibition [1.1.1, 1.1.3]